SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $142,000 | -16.5% | 15,051 | -20.8% | 0.00% | -20.0% |
Q2 2020 | $170,000 | +45.3% | 18,992 | +3.5% | 0.01% | 0.0% |
Q1 2020 | $117,000 | -53.4% | 18,344 | -38.9% | 0.01% | +25.0% |
Q4 2019 | $251,000 | -7.7% | 30,000 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $272,000 | -15.8% | 30,000 | 0.0% | 0.01% | -33.3% |
Q2 2019 | $323,000 | +70.0% | 30,000 | +200.0% | 0.01% | +50.0% |
Q1 2018 | $190,000 | -61.4% | 10,000 | -66.7% | 0.01% | -53.8% |
Q4 2017 | $492,000 | -34.4% | 30,000 | -40.0% | 0.01% | -53.6% |
Q3 2017 | $750,000 | +13.6% | 50,000 | -33.3% | 0.03% | 0.0% |
Q2 2017 | $660,000 | +49.3% | 75,000 | -11.8% | 0.03% | +55.6% |
Q1 2017 | $442,000 | +70.7% | 85,000 | 0.0% | 0.02% | +38.5% |
Q4 2016 | $259,000 | -34.3% | 85,000 | 0.0% | 0.01% | -45.8% |
Q3 2016 | $394,000 | +107.4% | 85,000 | +159.1% | 0.02% | +60.0% |
Q2 2016 | $190,000 | -15.9% | 32,805 | +162.4% | 0.02% | +200.0% |
Q1 2014 | $226,000 | +24.2% | 12,500 | -4.4% | 0.01% | +25.0% |
Q4 2013 | $182,000 | – | 13,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
Leisure Capital Management | 43,008 | $131,000 | 0.12% |
Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |